Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Market Cap	58.08B +0.1%
Revenue (ttm)	76.74B -6.5%
Net Income	2.12B
EPS	222.54
Shares Out	8.83M
PE Ratio	29.57
Forward PE	n/a
Dividend	95.47 (1.45%)
Ex-Dividend Date	Dec 29, 2025

Volume	716,006
Average Volume	81,533
Open	6,320.00
Previous Close	6,320.00
Day's Range	6,220.00 - 7,320.00
52-Week Range	6,010.65 - 9,226.11
Beta	0.86
RSI	57.73
Earnings Date	Mar 19, 2026

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1984
• Employees: 104
• Stock Exchange: KOSDAQ
• Ticker Symbol: 038070